Sabra Health Care REIT, Inc.
SBRA
$17.87
$0.412.35%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 96.04M | 96.07M | 94.56M | 99.10M | 91.78M |
Total Other Revenue | 87.72M | 86.88M | 83.66M | 77.13M | 74.38M |
Total Revenue | 183.76M | 182.95M | 178.22M | 176.22M | 166.15M |
Cost of Revenue | 59.76M | 59.71M | 58.36M | 54.59M | 53.86M |
Gross Profit | 124.00M | 123.24M | 119.86M | 121.63M | 112.30M |
SG&A Expenses | 12.73M | 13.03M | 12.40M | 12.74M | 11.89M |
Depreciation & Amortization | 43.49M | 42.31M | 42.72M | 41.68M | 42.91M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 115.98M | 115.05M | 113.48M | 109.01M | 108.66M |
Operating Income | 67.78M | 67.90M | 64.74M | 67.21M | 57.49M |
Income Before Tax | 40.72M | 47.08M | 29.52M | 24.41M | 26.71M |
Income Tax Expenses | 413.00K | 380.00K | -265.00K | 437.00K | 453.00K |
Earnings from Continuing Operations | 40.30M | 46.70M | 29.79M | 23.98M | 26.25M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 40.30M | 46.70M | 29.79M | 23.98M | 26.25M |
EBIT | 67.78M | 67.90M | 64.74M | 67.21M | 57.49M |
EBITDA | 111.27M | 105.34M | 107.46M | 108.89M | 100.41M |
EPS Basic | 0.17 | 0.20 | 0.13 | 0.10 | 0.11 |
Normalized Basic EPS | 0.11 | 0.11 | 0.09 | 0.10 | 0.08 |
EPS Diluted | 0.17 | 0.20 | 0.13 | 0.10 | 0.11 |
Normalized Diluted EPS | 0.11 | 0.11 | 0.09 | 0.10 | 0.08 |
Average Basic Shares Outstanding | 237.89M | 236.60M | 234.29M | 231.62M | 231.45M |
Average Diluted Shares Outstanding | 240.30M | 239.64M | 237.04M | 233.75M | 233.37M |
Dividend Per Share | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 |
Payout Ratio | 177.09% | 152.00% | 235.93% | 289.68% | 264.51% |